Suppr超能文献

实施心力衰竭患者过渡时期药物管理干预(MaTI):改善过渡时期医疗照护中药物管理安全性和连续性(ISCOMAT)群组随机对照试验的过程评估。

Implementing a Medicines at Transitions Intervention (MaTI) for patients with heart failure: a process evaluation of the Improving the Safety and Continuity Of Medicines management at Transitions of care (ISCOMAT) cluster randomised controlled trial.

机构信息

School of Pharmacy and Medical Sciences, University of Bradford, Bradford, UK.

Wolfson Centre for Applied Health Research, Bradford, UK.

出版信息

BMC Health Serv Res. 2024 Oct 9;24(1):1210. doi: 10.1186/s12913-024-11487-x.

Abstract

BACKGROUND

Heart failure is a major global health challenge incurring a high rate of mortality, morbidity and hospitalisation. Effective medicines management at the time of hospital discharge into the community could reduce poor outcomes for people with heart failure. Within the Improving the Safety and Continuity Of Medicines management at Transitions of care (ISCOMAT) programme, the Medicines at Transitions Intervention (MaTI) was co-designed to improve such transitions, with a cluster randomised controlled trial to test effectiveness. The MaTI includes a patient toolkit and transfer of discharge medicines information to community pharmacy. This paper aims to determine the degree to which the intervention was delivered, and identify barriers and facilitators experienced by staff for the successful implementation of the intervention.

METHODS

The study was conducted in six purposively selected intervention sites. A mixed-methods design was employed using hospital staff interviews, structured and unstructured ward observations, and routine trial data about adherence to the MaTI. A parallel mixed analysis was applied. Qualitative data were analysed thematically using the Framework method. Data were synthesised, triangulated and mapped to the Consolidated Framework for Implementation Research (CFIR).

RESULTS

With limited routines of communication between ward staff and community pharmacy, hospital staff found implementing community pharmacy-related steps of the intervention challenging. Staff time was depleted by attempts to bridge system barriers, sometimes leading to steps not being delivered. Whilst the introduction of the patient toolkit was often completed and valued as important patient education and a helpful way to explain medicines, the medicines discharge log within it was not, as this was seen as a duplication of existing systems. Within the CFIR the most applicable constructs were identified as 'intervention complexity' and 'cosmopolitanism' based on how well hospitals were networked with community pharmacies, and the availability of hospital resources to facilitate this.

CONCLUSION

The MaTI was generally successfully implemented, particularly the introduction of the toolkit. However, implementation involving community pharmacy was more challenging and more effective communication systems are needed to support wider implementation.

TRIAL REGISTRATION

11/04/2018 ISRCTN66212970. https://www.isrctn.com/ISRCTN66212970 .

摘要

背景

心力衰竭是一个全球性的主要健康挑战,导致高死亡率、发病率和住院率。在出院到社区的过程中,有效的药物管理可以降低心力衰竭患者的不良结局。在改善过渡时期的药物管理的安全性和连续性(ISCOMAT)计划中,药物过渡干预(MaTI)是共同设计的,以改善这种过渡,进行了一项群组随机对照试验来测试其效果。MaTI 包括一个患者工具包和将出院药物信息转移到社区药房。本文旨在确定干预措施的实施程度,并确定工作人员在成功实施干预措施方面遇到的障碍和促进因素。

方法

该研究在六个有目的选择的干预点进行。采用混合方法设计,对医院工作人员进行访谈、结构化和非结构化病房观察,并对遵守 MaTI 的常规试验数据进行分析。应用平行混合分析。使用框架方法对定性数据进行主题分析。对数据进行综合、三角剖分,并映射到实施研究的综合框架(CFIR)。

结果

由于病房工作人员与社区药房之间的沟通惯例有限,医院工作人员发现实施与社区药房相关的干预措施步骤具有挑战性。工作人员的时间因试图克服系统障碍而被耗尽,有时导致步骤无法完成。虽然引入患者工具包通常是完成的,并被认为是重要的患者教育和解释药物的有用方式,但其中的药物出院日志并未被采用,因为这被视为现有系统的重复。在 CFIR 中,根据医院与社区药房的网络连接程度以及医院资源的可用性来促进这一点,最适用的结构是“干预复杂性”和“世界主义”。

结论

MaTI 通常实施得比较成功,特别是工具包的引入。然而,涉及社区药房的实施更具挑战性,需要更有效的沟通系统来支持更广泛的实施。

试验注册

2018 年 4 月 11 日 ISRCTN66212970。https://www.isrctn.com/ISRCTN66212970。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8bc/11465536/94546ad473a7/12913_2024_11487_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验